Vendor, Irvine, CA
Immport Therapeutics Inc.
UEI ZJAMPJY7M149, CAGE 4C5L7
1 award and $300,000 obligated between September 9, 2024 and March 24, 2025, 100% under full and open competition, against 4.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $300,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93024C00044Definitive Contract, September 9, 2024, Full and Open Competition, 4 offers | National Institutes of Health NiaidNational Institutes of Health | SBIR 133 - AntigenNAICS 541715, PSC AN11 | $300,000 |
- Places of performance
- California
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 1 awards